Kyeyeon Hur is Senior Director of CMC at Samsung Biologics, where she leads the CMC Support Team in the CDO Center, directing analytical method development and formulation development. Prior to joining Samsung Biologics, she served as a CMC Project Manager at Serum Life Science Europe and as Chief Development Officer at MediMab Bio, where she was responsible for overall product development. Earlier in her career, she led the Manufacturing Technology Group at Samsung Bioepis, where she executed drug substance technology transfer for clinical manufacturing and PPQ campaigns. She holds a Ph.D. in Bioscience and Bioengineering from POSTECH (Pohang University of Science and Technology).